BRONCHODEX PASTILLES 1.5MG SAVEUR MENTHE 1.5 MG
DOMIPHEN BROMIDE : 1.5 MG · DIN 00616133 · PRODEMDIS ENR.
Health Canada status: CANCELLED POST MARKET
What is BRONCHODEX PASTILLES 1.5MG SAVEUR MENTHE?
BRONCHODEX PASTILLES 1.5MG SAVEUR MENTHE 1.5 MG contains DOMIPHEN BROMIDE : 1.5 MG. It is listed in the Health Canada Drug Product Database under DIN 00616133, held by PRODEMDIS ENR., supplied as LOZENGE for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 15-Jul-2010. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00616133 |
|---|---|
| Brand name | BRONCHODEX PASTILLES 1.5MG SAVEUR MENTHE |
| Generic / active ingredient | DOMIPHEN BROMIDE : 1.5 MG |
| Manufacturer | PRODEMDIS ENR. |
| Strength | 1.5 MG |
| Dosage form | LOZENGE |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A01AB06 DOMIPHEN |
| AHFS class | 52:04.92 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 15-Jul-2010 |
| Original market date | 1983-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code A01AB06 DOMIPHEN. 0 of 12 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ANTISEPTIQUE PASTILLE 1.5MG CERISE | 1.5 MG | LOZENGE | PRODEMDIS ENR. | CANCELLED POST MARKET | DIN 00873519 |
| ANTISEPTIQUE PASTILLE 1.5MG CITRON | 1.5 MG | LOZENGE | PRODEMDIS ENR. | CANCELLED POST MARKET | DIN 00873551 |
| ANTISEPTIQUE PASTILLE 1.5MG MENTHE | 1.5 MG | LOZENGE | PRODEMDIS ENR. | CANCELLED POST MARKET | DIN 00873527 |
| ANTISEPTIQUE PASTILLE 1.5MG MIEL EUCALYPTUS | 1.5 MG | LOZENGE | PRODEMDIS ENR. | CANCELLED POST MARKET | DIN 00873535 |
| BRONCHODEX PASTILLE 1.5MG MIEL EUC | 1.5 MG | LOZENGE | PRODEMDIS ENR. | CANCELLED POST MARKET | DIN 00846511 |
| BRONCHODEX PASTILLES 1.5MG SAVEUR CERISE | 1.5 MG | LOZENGE | PRODEMDIS ENR. | CANCELLED POST MARKET | DIN 00616168 |
| BRONCHODEX PASTILLES 1.5MG SAVEUR CITRON | 1.5 MG | LOZENGE | PRODEMDIS ENR. | CANCELLED POST MARKET | DIN 00616141 |
| ORA-SEPTIC CERISES LOZ 1.5MG | 1.5 MG | LOZENGE | PRODEMDIS ENR. | CANCELLED POST MARKET | DIN 00793388 |
| ORASEPTIC PASTILLE ANTISEP 1.5MG CITRON | 1.5 MG | LOZENGE | PRODEMDIS ENR. | CANCELLED POST MARKET | DIN 01942883 |
| ORASEPTIC PASTILLE ANTISEP 1.5MG MENTHE | 1.5 MG | LOZENGE | PRODEMDIS ENR. | CANCELLED POST MARKET | DIN 01942891 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Request a quote for BRONCHODEX PASTILLES 1.5MG SAVEUR MENTHE
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.